Health

Enrollment in Medicare Advantage has steadily increased over the past two decades. The number of MA enrollees grew from about 11 million (25% of total Medicare beneficiaries) in 2010 to …

Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The consulting firm …

A Revolution Medicines drug helped patients pancreatic cancer live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in …

In life sciences, AI usually makes headlines for drug discovery, molecule design or clinical insights. Behind the scenes, though, the fastest and most repeatable wins are showing up in FDA-oriented …

As a practicing emergency physician, I appreciate watching HBO’s The Pitt, because it offers a reasonably realistic depiction of what it’s like to work on the front lines of today’s …

To some, President Donald Trump’s budget proposal might be adding an insult to an injury. Last year, the federal government made significant cuts to healthcare coverage in Medicaid via the …

Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for improving this class of therapies. This week, two startups revealed …

The Department of Justice is taking aim at two large health systems over contracts that the agency says stifle competition and keep patients from receiving affordable care. The lawsuits, both …

If ever there was a time for federal regulators and lawmakers to ensure that all medications are safe, contain high-quality ingredients, and are held to rigorous production standards, it would …

A significant number of non-small cell lung cancer patients (NSCLC) patients miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, and incomplete patient journey data. A …